Soleno Therapeutics (SLNO) Announces Board Changes

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. BA
6. META
7. SPY
8. INTC
9. JBLU
10. HOOD

Go back to Soleno Therapeutics (SLNO) Announces Board Changes

Soleno Therapeutics Announces Updates to its Board of Directors

August 15, 2024 8:00 AM EDT

Ernest Mario, Ph.D. steps down as Chair for health reasons; Matthew Pauls, J.D., M.B.A. assumes role of Lead Independent Director

Dawn Carter Bir, seasoned biotech executive with significant commercial and strategic expertise, joins the Board of Directors

REDWOOD CITY, Calif., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced updates to its Board of Directors. Dawn Carter Bir, a seasoned biotechnology executive with over 30... More